E-selectin gene (S128R) polymorphism in hemorrhagic stroke: comparison with ischemic stroke

Area of Science:

• Genetics
• Neurology
• Immunology

Background:

• Genetic variations in inflammatory genes are increasingly implicated in stroke pathogenesis.
• E-selectin plays a role in leukocyte adhesion to endothelial cells, potentially contributing to secondary brain damage.

Purpose of the Study:

• To investigate the association between E-selectin S128R polymorphism and hemorrhagic stroke.
• To compare genotypic and allelic variations of E-selectin S128R between ischemic and hemorrhagic stroke patients in a South Indian population.

Main Methods:

• Case-control study involving 250 hemorrhagic stroke patients and 250 controls from Andhra Pradesh.
• Genotyping performed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
• Statistical analysis included odds ratio, 95% confidence interval, and chi-square tests.

Main Results:

• Significant differences in allelic and genotypic frequencies of E-selectin S128R polymorphism were observed between hemorrhagic stroke patients and controls (p<0.001).
• The AC genotype was identified as a significant risk factor for hemorrhagic stroke.
• Significant differences in AC genotype and C allele frequencies were found when comparing ischemic and hemorrhagic stroke patients (p<0.001).

Conclusions:

• The E-selectin S128R polymorphism, particularly the AC genotype, is a significant risk factor for hemorrhagic stroke in the studied population.
• Distinct genotypic and allelic variations between ischemic and hemorrhagic stroke suggest differential roles in stroke subtypes.
• E-selectin S128R-mediated leukocyte amplification may contribute more significantly to secondary brain damage in hemorrhagic stroke.